Sign in
4

Changes in Ownership

Enliven Therapeutics, Inc. Filed Acc 0001415889-24-010520

Director sold 3,485 shares at $19.15 ($66,729)

  • Director acquired 3,485 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Ballal Rahul D. · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-04-04 Exercise or conversion : show line 1 in the form 10b5-1 +3,485 $12.60 $43,911 25,826 D
2024-04-04 Sale : show line 2 in the form 10b5-1 −3,485 $19.15 $66,729 22,341 D
Open-market sales · 3,485 sh · avg $19.15 · $66,729

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-04-04 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −3,485 62,420 D
Loading xslF345X05/form4-04092024_120438.xml…